Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats

Neuropharmacology

Volumn 48, Issue 7, 2005, Pages 1012-1020

  Shannon, Harlan E ^a   Eberle, Elizabeth Lutz ^a   Peters, Steven C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

6 Hz test; Antiepileptic drugs; Formalin test; Locomotor activity; Mice; Rats; Threshold electroshock test

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHLORDIAZEPOXIDE; ETHOSUXIMIDE; ETIRACETAM; FORMALDEHYDE; GABAPENTIN; LAMOTRIGINE; MORPHINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG MECHANISM; ELECTRIC SHOCK; LOCOMOTION; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

EID: 18044372830     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.01.013     Document Type: Article

References (60)

1. D. Ardid, Y. Lamberty, A. Alloui, M.A. Coudore-Civiale, H. Klitgaard, and A. Eschalier Antihyperalgesic effect of levetiracetam in neuropathic pain models in rats Eur. J. Pharmacol 473 2003 27 33
2. S. Arner, and B.A. Meyerson Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain Pain 33 1988 11 23
3. M. Backonja, A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. LaMoreaux, and E. Garofalo Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial J. Am. Med. Assoc 280 1998 1831 1836
4. M. Backonja Use of anticonvulsants for treatment of neuropathic pain Neurology 59 2002 S14 S17
5. M.E. Barton, B.D. Klein, H.H. Wolf, and H.S. White Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy Epilepsy Res. 47 2001 217 227
6. M.E. Barton, S.C. Peters, and H.E. Shannon Comparison of the role of glutamate receptors in the 6 Hz and maximal electroshock seizure models Epilepsy Res. 56 2003 17 26
7. S. Bischofs, M. Zelenka, and C. Sommer Evaluation of topiramate as an anti-hyperalgesic and neuroprotective agent in the peripheral nervous system J. Periph. Nerv. Sys. 9 2004 70 78
8. + channel blockers in the formalin test Eur. J. Pharmacol. 445 2002 231 238
9. B receptors: structure and function Pharmacol. Rev. 54 2002 247 264
10. F.G. Campbell, J.G. Graham, and K.J. Zilkha Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia J. Neurosurg. Neurol. Psychiatry 29 1966 265 267
11. T.J. Coderre, M.E. Fundytus, J.E. McKenna, S. Dalal, and R. Melzack The formalin test: a validation of the weighted-scores method of the behavioral pain rating Pain 54 1993 43 50
12. S.L. Collins, R.A. Moore, H.J. McQuay, and P. Wiffen Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review J. Pain Symptom Management 20 2000 449 458
13. D.A. Coulter, J.R. Huguenard, and D.A. Prince Characterization of ethosuximide reduction of low-threshold calcium current in thalamic relay neurons Ann. Neurol. 25 1989 582 593
14. A.H. Dickenson, and A.F. Sullivan 7a. Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 30 1988 349 360
15. A.H. Dickenson, and A.F. Sullivan Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurons Neurosci. Lett. 83 1987 207 211
16. D. Dubuisson, and S.G. Dennis The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats Pain 4 1977 161 174
17. E. Eisenberg, Y. Lurie, C. Braker, D. Daoud, and A. Ishay Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study Neurology 57 2001 505 509
18. M.J. Field, M.I. Gonzalez, R.J. Tallarida, and L. Singh Gabapentin and the neurokinin(1) receptor antagonist CI-1021 act synergistically in two rat models of neuropathic pain J. Pharmacol. Exp. Ther. 303 2002 730 735
19. M.J. Field, R.J. Oles, A.S. Lewis, S. McCleary, J. Hughes, and L. Singh Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents Br. J. Pharmacol. 121 1997 1513 1522
20. N.B. Finnerup, S.H. Sindrup, F.W. Bach, I.L. Johannesen, and T.S. Jensen Lamotrigine in spinal cord injury pain: a randomized controlled trial Pain 96 2002 375 383
21. D.J. Finney Probit analysis 1971 Cambridge University Press Cambridge
22. A. Fox, C. Gentry, S. Patel, A. Kesingland, and S. Bevan Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea pig Pain 105 2003 355 362
23. 2δ subunit of a calcium channel J. Biol. Chem. 271 1996 5768 5776
24. F.J. Gomez-Perez, R. Choza, J.M. Rios, A. Reza, E. Huerta, C.A. Aguilar, and J.A. Rull Nortriptyline-fluphenazine vs carbamazepine in the symptomatic treatment of diabetic neuropathy Arch. Med. Res. 27 1996 525 529
25. M.I. Gonzalez, M.J. Field, J. Hughes, and L. Singh Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain J. Pharmacol. Exp. Ther. 294 2000 444 450
26. C.G. Heapy, A. Jamieson, and N.J.W. Russell Afferent C-fiber and A-delta activity in models of inflammation Br. J. Pharmacol. 90 1987 164P
27. A.H. Hord, D.D. Denson, A.G. Chalfoun, and M.I. Azevedo The effect of systemic zonisamide (Zonegran) on thermal hyperalgesia and mechanical allodynia in rats with an experimental mononeuropathy Anesthesia Analgesia 96 2003 1700 1706
28. J.C. Hunter, K.R. Gogas, L.R. Hedley, L.O. Jacobson, L. Kassotakis, J. Thompson, and D.J. Fontana The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain Eur. J. Pharmacol. 324 1997 153 160
29. P.A. Insel Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout J.G. Hardman L.E. Limbird Goodman and Gilman's The pharmacologic basis of therapeutics 1995 McGraw-Hill New York 617 657
30. J.J. Idänpään-Heikkilä, and G. Guilbaud Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour Pain 79 1999 281 290
31. B receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis Eur. J. Pharmacol. 368 1999 205 211
32. T.M. Laughlin, K.V. Tram, G.L. Wilcox, and A.K. Birnbaum Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception J. Pharmacol. Exp. Ther. 302 2002 1168 1175
33. W. Löscher Basic pharmacology of valproate CNS Drugs 16 2002 669 694
34. W. Löscher, D. Honack, and C.P. Taylor Gabapentin increases amino-oxyacetic acid-induced GABA accumulation in several regions of rat brain Neurosci. Lett. 128 1991 150 154
35. B.A. Lynch, N. Lambeng, K. Nocka, P. Kensel-Hammes, S.M. Bajjalieh, A. Matagne, and B. Fuks The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc. Natl. Acad. Sci. USA 101 2004 9861 9866
36. 2+ channel blocker, on dorsal horn neuronal responses in rats Eur. J. Pharmacol. 415 2001 141 149
37. M.B. Max, S.C. Schafer, M. Culnane, R. Dubner, and R.H. Gracely Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen and placebo Clin. Pharmacol. Ther. 43 1988 363 371
38. G. McCleane 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomized, double-blind, placebo-controlled trial Pain 83 1999 105 107
39. G. McCleane Pharmacological management of neuropathic pain CNS Drugs 17 2003 1031 1043
40. R. Monks Psychotropic drugs P.D. Wall R. Melzack Textbook of pain 1994 Churchill Livingstone Edinburgh 963 989
41. M. Pappagallo, and E.J. Haldey Pharmacological management of postherpetic neuralgia CNS Drugs 17 2003 771 780
42. S. Puig, and L.S. Sorkin Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity Pain 64 1995 345 355
43. T. Reisine, and G. Pasternak Opioid analgesics and antagonists J.G. Hardman L.E. Limbird Goodman and Gilman's The pharmacologic basis of therapeutics 1995 New York McGraw-Hill 521 555
44. M. Rowbotham, N. Harden, B. Stacey, P. Bernstein, and L. Magnus-Miller Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial J. Am. Med. Assoc. 280 1998 1837 1842
45. H.E. Shannon, S.G. Holtzman, and D.C. Davis Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse J. Pharmacol. Exp. Ther. 199 1976 389 399
46. H.E. Shannon, and E.A. Lutz Effects of the I1 imidazoline/alpha2 adrenergic receptor agonist moxonidine in comparison with clonidine in the formalin test in the rat Pain 85 2000 161 167
47. H.E. Shannon, and E.A. Lutz Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats Neuropharmacology 42 2002 253 261
48. D.M. Simpson, J.C. McArthur, R. Olney, D. Clifford, Y. So, D. Ross, B.J. Baird, P. Barrett, and A.E. Hammer Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial Neurology 60 2003 1508 1514
49. C.P. Taylor, N.S. Gee, T.-Z. Su, J. Kocsis, D. Welty, J.P. Brown, D.J. Dooley, P. Boden, and L. Singh A summary of the mechanistic hypotheses of gabapentin pharmacology Epilepsy Res. 29 1998 233 249
50. S.M. Todorovic, A. Meyenburg, and V. Jevtovic-Todorovic Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker Brain Res. 951 2002 336 340
51. S.M. Todorovic, A.J. Rastogi, and V. Jevtovic-Todorovic Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats Br. J. Pharmacol. 140 2003 255 260
52. I.W. Tremont-Lukats, C. Megeff, and M.-M. Backonja Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy Drugs 60 2000 1029 1052
53. K. Vestergaard, G. Andersen, H. Gottrup, B.T. Kristensen, and T.S. Jensen Lamotrigine for central poststroke pain: a randomized controlled trial Neurology 56 2001 184 190
54. H. Wheeler-Aceto, F. Porreca, and A. Cowan The rat paw formalin test: comparison of noxious agents Pain 40 1990 229 238
55. H.S. White, M. Johnson, H.H. Wolf, and H.J. Kupferberg The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models Ital. J. Neurol. Sci. 16 1995 73 77
56. A. Wieczorkiewicz-Plaza, P. Plaza, R. Maciejewski, M. Czuczwar, and K. Przesmycki Effect of topiramate on mechanical allodynia in neuropathic pain model in rats Pol. J. Pharmacol. 56 2004 275 278
57. D.M. Woodbury, and V.D. Davenport Design and use of new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern Arch. Int. Pharmacodyn. Ther. 92 1952 97 104
58. M.H. Yoon, and T.L. Yaksh The effect of intrathecal gabapentin on pain behavior and hemodynamics on the formalin test in the rat Anesthesia Analgesia 89 1999 434 439
59. J.M. Zakrzewska, and P.N. Patsalos Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia Pain 95 2002 259 266
60. J.M. Zakrzewska, Z. Chaudhry, T.J. Nurmikko, D.W. Patton, and E.L. Mullens Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial Pain 73 1997 223 230